Biotech’s Capital Intensity Challenge: A Post-Mortem on 2007’s Biggest Deals

Truth from Booth: there is no correlation between the amount of venture capital raised by a biotech and it's ultimate outcome. 

I suspect that huge VC rounds just incent management to take on more risks beyond their control.

Read Bruce's full article here: http://pocket.co/s8kDC

Sent from Pocket - Get it free!